Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 4 of 4 entries
View as:

A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4)

Phase: N/A Priority: Normal
NCT ID: NCT05153499 Org: User:
Start: 11/15/21 End: 02/24/23 Due: 02/24/24

Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection

Phase: N/A Priority: Normal
NCT ID: NCT03497806 Org: User:
Start: 05/01/18 End: 04/01/21 Due: 04/01/22

Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT)

Phase: N/A Priority: Normal
NCT ID: NCT03829878 Org: User:
Start: 05/31/20 End: 12/31/21 Due: 12/31/22

Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff

Phase: N/A Priority: Normal
NCT ID: NCT03110133 Org: User:
Start: 05/08/17 End: 06/18/20 Due: 06/18/21